Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboxytherapy vs tranexamic acid for melasma
IRCT20250309065002N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in melasma (2 arms), sponsored by Arak University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20250309065002N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250309065002N1.